Advances in the diagnosis and management of neurocysticercosis

References

• Garcia HH, Gonzales AE, Evans CA, Gilman RH. Taenia solium cysticercosis. Lancet362, 547–556 (2003).
   PubMed Web of Science ®Google Scholar
• Carpio A. Neurocysticercosis: an update. Lancet Infect. Dis.2, 751–762 (2002).
   PubMed Web of Science ®Google Scholar
• Garcia HH, Wittner M, Coyle C, Tanowitz H, White AC Jr. Cysticercosis. In: Tropical Infectious Diseases: Principles, Pathogens, and Practice (Volume 2). Guerrant RL, Walker DH, Weller PF (Eds). Elsevier Churchill Livingstone, PA, USA, 1289–1303 (2006).
   Google Scholar
• Yancey L, White AC. Taenia solium and neurocysticercosis. In: Immigrant Medicine. Walker P, Barnett E (Eds). (In press).
   Google Scholar
• Pawloski Z, Allan J, Sarti E. Control of Taenia solium taeniasis/cysticercosis: from research towards implementation. Int. J. Parasitol.35, 1221–1232 (2005).
   PubMedGoogle Scholar
• Phiri IK, Ngowi H, Afonso S et al. The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Trop.87, 13–23 (2003).
   PubMed Web of Science ®Google Scholar
• Mafojane NA, Appleton CC, Michael LM, Willingham AL. The current status of neurocysticercosis in Eastern and Southern Africa. Acta Trop.87, 25–33 (2003).
   PubMed Web of Science ®Google Scholar
• Wallin M, Kurtzke J. Neurocysticercosis in the United States: review of an important emerging infection. Neurology63, 1559–1564 (2004).
   PubMed Web of Science ®Google Scholar
• de la Garza Y, Graviss EA, Daver NG et al. Epidemiology of neurocysticercosis in Houston, Texas. Am. J. Trop. Med. Hyg.73, 766–770 (2005).
   PubMedGoogle Scholar
• Ong S, Talan DA, Moran GJ et al. Neurocysticercosis in radiographically imaged seizure patients in U.S emergency departments. Emerg. Infect. Dis.8, 608–613 (2002).
   PubMed Web of Science ®Google Scholar
• White AC Jr, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem. Immunol.66, 209–230 (1997).
   Google Scholar
• Molinari JL, Mejia H, White AC Jr et al. Taenia solium: a cysteine protease secreted by metacestodes depletes human CD4 lymphocytes in vitro. Exp. Parasitol.94, 133–142 (2000).
   PubMed Web of Science ®Google Scholar
• Stringer JL, Marks LM, White AC, Robinson P. Epileptogenic activity of granulomas associated with murine cysticercosis. Exp. Neurol.183, 532–536 (2003).
   PubMed Web of Science ®Google Scholar
• Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol.4, 653–661 (2005).
   PubMed Web of Science ®Google Scholar
• Nash TE, Del Brutto OH, Butman JA. Calcific neurocysticercosis and epileptogenesis. Neurology62, 1934–1938 (2004).
   PubMed Web of Science ®Google Scholar
• Yancey LS, Diaz-Marchan PJ, White AC Jr. Cysticercosis: recent advances in diagnosis and management of neurocysticercosis. Curr. Infect. Dis. Rep.7(1), 39–47 (2005).
   PubMedGoogle Scholar
• Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia39, 1025–1040 (1998).
   PubMed Web of Science ®Google Scholar
• Allan JC, Velasquez-Tohom M, Torres-Alvarez R, Yurrita P, Garcia-Noval J. Field trial of the coproantigen-based diagnosis of Taenia solium taeniasis by enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg.54, 352–356 (1996).
   PubMed Web of Science ®Google Scholar
• Garcia HH, Del Brutto OH, Nash TE, White AC, Tsang VC, Gilman RH. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am. J. Trop. Med. Hyg.72(1), 3–9 (2005).
   PubMed Web of Science ®Google Scholar
• Del Brutto OH, Rajshekhar V, White AC et al. Proposed diagnostic criteria for neurocysticercosis. Neurology57, 177–183 (2001).
   PubMed Web of Science ®Google Scholar
• Prasad S, MacGregor R, Tebas P, Rodriguez L, Bustos J, White AC Jr. Management of potential neurocysticercosis in patients with HIV infection. Clin. Infect. Dis.42, E30–E34 (2006).
   PubMed Web of Science ®Google Scholar
• Rajshekhar V, Chandy MJ. Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol. Scand.96, 76–81 (1997).
   PubMed Web of Science ®Google Scholar
• Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J. Infect. Dis.159, 50–59 (1989).
   PubMed Web of Science ®Google Scholar
• Prabhakaran V, Rajshekhar V, Murrell KD, Oommen A. Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients. Trans. R. Soc. Trop. Med. Hyg.98, 478–484 (2004).
   PubMed Web of Science ®Google Scholar
• Hancock K, Khan A, Williams FB et al. Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis. J. Clin. Microbiol.41, 2577–2586 (2003).
   PubMed Web of Science ®Google Scholar
• Hancock K, Pattabhi S, Greene R et al. Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis. Mol. Biochem. Parasitol.133(1), 115–124 (2004).
   PubMed Web of Science ®Google Scholar
• Hancock K, Pattabhi S, Whitfield F et al. Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis. Mol. Biochem. Parasitol.147(1), 109–117 (2006).
   PubMed Web of Science ®Google Scholar
• Garcia HH, Parkhouse RM, Gilman RH et al. Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans. R. Soc. Trop. Med. Hyg.94(6), 673–676 (2000).
   PubMed Web of Science ®Google Scholar
• Garcia HH, Evans CA, Nash TE et al. Current consensus guidelines for treatment of neurocysticercosis. Clin. Microbiol. Rev.15, 747–756 (2002).
   PubMed Web of Science ®Google Scholar
• Del Brutto OH, Roos KL, Coffey CS, Garcia HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann. Intern. Med.145, 43–51 (2006).
   PubMed Web of Science ®Google Scholar
• Garcia HH, Pretell EJ, Gilman RH et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N. Engl. J. Med.350, 249–258 (2004).
   PubMed Web of Science ®Google Scholar
• Nash TE, Singh G, White AC et al. Treatment of neurocysticercosis – current status and future research needs. Neurology67(7), 1120–1127 (2006).
   PubMed Web of Science ®Google Scholar
• Psarros TG, Krumerman J, Coimbra C. Endoscopic management of supratentorial ventricular neurocysticercosis: case series and review of the literature. Minim. Invasive Neurosurg.46, 331–334 (2003).
   PubMedGoogle Scholar
• Proaño JV, Madrazo I, Avelar F, Lopez-Felix B, Diaz G, Grijalva I. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N. Engl. J. Med.345, 879–885 (2001).
   PubMed Web of Science ®Google Scholar
• Göngora-Rivera F, Soto-Hernández JL, González Esquivel D et al. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology66, 436–438 (2006).
   PubMed Web of Science ®Google Scholar
• Jeri C, Gilman RH, Lescano AG et al. Species identification after treatment for human taeniasis. Lancet363(9413), 949–950 (2004).
   PubMedGoogle Scholar
• Sarti E, Flisser A, Schantz PM et al. Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. Am. J. Trop. Med. Hyg.56, 127–132 (1997).
   PubMed Web of Science ®Google Scholar
• Garcia HH, Gonzales AE, Gilman RH et al. Combined human and porcine mass chemotherapy for the control of T. solium. Am. J. Trop. Med. Hyg.74(5), 850–855 (2006).
   PubMed Web of Science ®Google Scholar